XML 88 R59.htm IDEA: XBRL DOCUMENT v3.23.4
Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Operating expenses                      
Research and development $ 3,342,644     $ 3,044,024       $ 8,899,904 $ 7,545,628 $ 10,232,366 $ 2,753,966
General and administrative 1,984,890     1,909,536       6,459,578 5,592,727 8,433,448 3,397,169
Total operating expenses 5,327,534     4,953,560       15,359,482 13,138,355 18,665,814 6,151,135
Operating loss (5,327,534)     (4,953,560)       (15,359,482) (13,138,355) (18,665,814) (6,151,135)
Other income                      
Change in fair value of derivative liabilities                     (867,000)
Change in fair value of warrant liability                     (6,109)
Grant income 27,441     654,949     $ 696,669 895,786 696,669 (1,080,436) (278,333)
Interest expense                     (95,070)
Interest income 131     9,001       5,148 10,774 20,410 664
Total other income 27,572     663,950       900,934 707,443 1,100,846 (692,264)
Net loss $ (5,299,962) $ (4,341,653) $ (4,816,934) $ (4,289,610) $ (4,671,232) $ (3,470,070)   $ (14,458,548) $ (12,430,912) $ (17,564,968) $ (6,843,399)
Weighted-average common shares outstanding, Basic 3,157,194     648,862       1,708,889 648,862 12,977,234 8,425,880
Weighted-average common shares outstanding, Diluted 3,157,194     648,862       1,708,889 648,862    
Net loss per share, Basic $ (1.68)     $ (6.61)       $ (8.46) $ (19.16) $ (1.35) $ (0.81)
Net loss per share, Diluted $ (1.68)     $ (6.61)       $ (8.46) $ (19.16)